Testing gene editing techniques in pigs
Swine Somatic Cell Gene Editing Testing Center
This study is all about helping scientists create and test new gene editing techniques using pigs, which can lead to better treatments for health conditions, and it’s designed for researchers who want to explore these exciting possibilities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10928238 on NIH RePORTER |
What this research studies
This research focuses on providing essential services to the somatic cell genome editing community by producing and supplying swine biomedical models. It evaluates the safety and effectiveness of various gene editing strategies and aims to determine their therapeutic value and timing. The project also involves managing communication and logistics for researchers, ensuring that innovative gene editing methods can be tested and potentially translated into clinical applications. By maintaining breeding colonies and specialized facilities, the research supports the development of new therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research would be those involved in or affected by conditions that could benefit from somatic cell genome editing therapies.
Not a fit: Patients who are not involved in gene therapy research or do not have conditions targeted by somatic cell genome editing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in gene therapies that may improve treatment options for various diseases.
How similar studies have performed: Other research in gene editing has shown promising results, indicating that this approach has the potential for significant breakthroughs in medical treatment.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Wells, Kevin Dale — University of Missouri-Columbia
- Study coordinator: Wells, Kevin Dale
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.